Walking and Fatigue in People with Cerebral Palsy: Brief Report

Husain, Sarrah; Wrightson, James; Johnson, Erika; Brunton, Laura; Condliffe, Elizabeth G.

doi:10.1080/17518423.2022.2053222

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies also supported this result, which stated that fatigue has no significant association with walking ability. Several statements say that subjective fatigue affects walking ability, but objective fatigue impacts individual weakness, meaning it impacts the quality of walking capability, not ability 28 . Previous studies assessed the relationship between fatigue and walking endurance in MG patients using the 6-minute walking test, which found a decrease in walking speed between the first and sixth min 26 .…”

Section: Discussionmentioning

confidence: 99%

Correlation of fatigue on walking ability in myasthenia gravis patients: a cross-sectional study

Kartika,

Subadi,

Pawana

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Introduction: Myasthenia gravis (MG) is a neuromuscular junction autoimmune disease characterised of intermittent muscle weakness that increases with activity and recovers with rest. Objective: Analysing the correlation of fatigue on walking ability in MG patients. Methods: This study used a cross-sectional design with consecutive sampling. Participants MG patients took in this trial. Data collection encompasses fatigue and walking ability, with fatigue being assessed using the fatigue severity scale (FSS) and walking ability being assessed using the 10-metre walking test. The 10-metre walking test assessment contains three components: comfortable walking speed (CWS), maximum walking speed (MWS), and natural cadence. The statistical analysis used in this study includes the Pearson correlation and Spearman rank tests with P<0.05. Results: The number of participants was 23 MG patients, and most of the participant was female (69.6%). The participant’s fatigue value was 5.46±1.13, including MGFA 1=5.32±1.15, MGFA 2A=5.5±1.11, and MGFA 2B=5.61±1.30. Meanwhile, the participant’s walking abilities included CWS of 1.10±0.11 m/s, MWS of 1.31±0.15 m/s, and natural cadence of 110.91±7.74 steps/min. No significant correlation of fatigue on walking ability including FSS vs. CWS (r=−0.141; P=0.520), FSS vs MWS (r=−0.169; P=0.442), and FSS vs. natural cadence (r=−0.050; P=0.822). Conclusion: There was no significant correlation between fatigue and walking ability in MG patients who had MGFA 1, MGFA 2A, and MGFA 2B.

show abstract

Section: Discussionmentioning

confidence: 99%